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ABSTRACT: It is well established that smoking has potent effects on a number of
parameters including food intake, body weight, metabolism, and blood pressure.  For
example, it is well documented that 1) there is an inverse relationship between
smoking and body weight, and 2) smoking cessation is associated with weight gain.
However, there is increasing evidence that smoking can exert deleterious effects on
energy balance through maternal exposure during fetal development.  Specifically,
there appears to be an increased incidence of metabolic disease (including obesity),
and cardiovascular disease in children and adults that were exposed to smoke during
fetal development.   The present review will examine the relationship between
maternal  smoke  and  adult  disease  in  offspring.   The  epidemiological  studies
highlighting this relationship will be reviewed as well as the experimental animal
models that point to potential mechanisms underlying this relationship.   A better
understanding of how smoking effects changes in energy balance may lead to
treatments to ameliorate the long-lasting effects of perinatal exposure to smoke as
well as increasing the health benefits associated with smoking cessation.
Smoking And The Fetal Origins Of
Disease
I. Introduction - Fetal Programming of
Adult Disease
Recently  there  has  been  increased
attention paid to the hypothesis that some
diseases that have been considered to be
diseases of adulthood (e.g., obesity, type II
diabetes,  cardiovascular  disease,
hypertension, and some cancers) may have
their origins in fetal development.  This is
most commonly referred to as either the
“developmental origins of disease” or the
“fetal  origins  of  disease”  (1-7).   The
hypothesis states that the susceptibility to
develop some diseases is determined in
part by the intrauterine and early postnatal
environment,  i.e.,  perturbations  to  the
early  environment  (e.g.,  nutritional
deficits)  can  significantly  increase
susceptibility to develop disease later in
life.   The association between poor fetal
and newborn growth and the subsequent
development  of  obesity  is  a  commonly
cited example of this phenomenon (7; 8).
The epidemiological studies that reported
this association led to the formulation of
the  “thrifty  phenotype  hypothesis”  (9).
This  hypothesis  stated  that  a  poor
nutritional  environment  for  the  fetus,
brought  on  by  either  malnutrition  or
placental  dysfunction,  can  induce  an
adaptive  response  that  will  optimize
growth and development later in life.  The
adaptive  response  (which  may  include
changes in circulating hormones, receptor
sensitivity,  regulatory  enzymes,  central
nervous system changes), would lead to
potential increased survival of the adult
individual under conditions of marginal
nutritional  supply.   However,  under
conditions  of  nutritional  abundance  the
result will be maladaptive with increased
incidence  of  obesity,  hyperlipidemia,
hypertension  and  type  II  diabetes  in
adulthood.6 Bergen H
One  of  the  first  and  best  documented
examples  of  this  phenomenon  was  the
development of obesity in individuals 20
years  after  they  were  born  during  the
Dutch famine of 1944-1945.  Individuals
were at greater risk of developing obesity
following  exposure  to  under-nutrition
during late gestation and early post-natal
periods (10).   The last 30 years has seen
numerous  epidemiological  studies
outlining  a  relationship  between
gestational nutrition together with birth
weight  (as  a  marker  of  impaired  fetal
growth) and subsequent diseases such as
obesity, type II diabetes, hypertension and
cardiovascular disease to name a few (1; 5;
11-15)  Epidemiological studies have now
been bolstered by an increasing number of
experimental  studies  demonstrating  a
relationship  between  perinatal  nutrition
and/or birth weight, and adult disease (2;
7; 16-19).  The mechanism(s) responsible
for  translating  fetal  effects  into  adult
disease are not well understood but several
candidates  include  imprinting  through
epigenetic programming.
Most of the research, with respect to early
programming of adult disease, has focused
on nutritional challenges (under- and over-
nutrition) on the subsequent development
of  adult  diseases.   However,  there  is
increasing evidence that long-lived effects
of  perinatal  perturbations  may  not  be
limited to nutritional influences but may
also  include  other  influences  such  as
maternal smoking.   The present review
will  focus  on  the  effects  of  maternal
smoking on the subsequent development
of diseases in the offspring.  It should be
noted  that  cigarette  smoke  contains
numerous  components  that  are
biologically active.  Although nicotine is a
dominant  factor  in  this  regard,  other
components  of  smoke  may  also  be
involved  in  mediating  the  detrimental
effects of smoke on fetal development and
the subsequent promotion of disease into
adulthood.
II. Smoking and Obesity
One of the first epidemiological studies
that  examined  the  effect  of  maternal
smoking on the subsequent development
of obesity was a birth cohort study of over
17,000 births and these individuals were
tracked at 16 and 33 years of age (20).
This study identified a significant effect of
maternal  smoking  on  the  subsequent
development of non-diabetic obesity, as
well as an effect on diabetes (see below).
In the offspring of mothers that smoked
during pregnancy, there was significant
increase in the incidence of obesity (at 33
years of age) and the magnitude of the
effect was greater in the offspring of heavy
smokers  than  the  offspring  of  medium
smokers.  Similar results were obtained in
a  study  of  over  6,000  children  (21).
Specifically, there was a dose dependent
association  between  maternal  smoking
during pregnancy and childhood obesity
(5-7 yrs. of age) that was independent of a
variety of lifestyle confounders or other
risk factors for obesity.   However, it is
also  known  that  maternal  smoking  can
significantly impair fetal growth (22; 23)
and  that  low  birth  weight  is  itself
associated  with  increased  incidence  of
obesity later in life (24).   In this clinical
scenario, i.e., obesity in individuals born
small for gestational age, the post-natal
and  early  developmental  period  is
characterized by a phenomenon referred to
as  “catch-up  growth”(22;  24-26).
Therefore,  obesity  due  to  maternal
smoking may be secondary to the effects
of maternal smoking on fetal growth; i.e.,
maternal smoking produces smaller babies
and smaller babies are more susceptible to
develop  a  variety  of  adult  diseases.
However,  it  should  be  noted  that  the
relationship  between  maternal  smoking
during  pregnancy  and  overweight  in
children is a complex one.  Specifically, a
more  recent  epidemiological  study
reported  that  the  likelihood  of  being
overweight  at  4.5  years  was  almost
doubled as a result of maternal smoking
during pregnancy.  Interestingly, the effect
of maternal smoking on overweight was
seen in normal birth weight children thatExposure To Smoke During Development: Fetal Programming Of Adult Disease 7
had the greatest weight gain in the first
few months of life as well as in high birth
weight children that had the least amount
of  weight  gain  after  birth  (27).   This
suggests  that  maternal  smoking  may
increase  susceptibility  to  develop
overweight and this can occur in normal
birth weight as well as high birth weight
children.
However, although catch-up growth may
be a factor in the subsequent development
of obesity, studies also suggest that the
effect of maternal smoking on obesity in
offspring  can  occur  independently  of
catch-up growth (21).  It was reported that
infants exposed to maternal smoke had
lighter birth weights but as they grew into
adolescence they tended to have greater
body  mass  index  and  this  tendency
increased  with  age  (28).   Importantly,
studies have reported that the association
between  maternal  smoking  on  obesity
remains  even  when  adjusted  for  birth
weight; i.e, maternal smoking exerts an
influence  independent  of  its  effects  on
fetal growth (21; 28; 29).  In a subsequent
study it was also reported that the effects
of  maternal  smoke  on  development  of
obesity was observed in children 5-7 years
of age and that if mothers that otherwise
smoked, abstained during pregnancy and
then resumed smoking after childbirth, the
association was no longer observed (30).
This  clearly  suggests  that  intrauterine
exposure to maternal smoke, rather than
other family or lifestyle factors, can exert
profound  influences  on  regulation  of
energy  balance  that  can  be  detected  as
early as 3 to 5 years of age (30; 31).  For
example, the size of the effect of maternal
smoking on childhood obesity was as great
as that observed in studies linking obesity
with  frequent  television  viewing  and
playing video games (21).
In a study that examined the relationship
of  maternal  smoking  to  obesity  in
American  Indian  children  there  was  a
significant  effect  of  maternal  smoking
during pregnancy on overweight at three
years of age (31).  It is also of interest to
note that the effect was independent of
birth weight (and mother’s pre-pregnancy
weight).   Given  that  smoking  has  also
been linked to low birth weight and that
low  birth  weight  has  been  linked  to
obesity;  the  dissociation  between  these
two variables in this study indicates that
the  effect  of  smoking  is  not  simply
through an effect on birth weight (32; 33).
An important issue regarding the effect of
maternal smoke on fetal development and
subsequent health effects is determining
the  sensitivity  of  the  fetus  to  the
detrimental  effects  of  smoke.  From  a
public  health  perspective,  it  is  vital  to
know whether smoking is harmful to the
fetus in the first trimester when women
who smoke and do not know that they are
pregnant, will be unintentionally exposing
their  fetuses  to  the  harmful  effects  of
smoke.  In a recent study it was reported
that there was no difference in the effect of
maternal smoking between mothers that
smoked throughout pregnancy and those
that smoked only during the first trimester
on  subsequent  development  of  obesity
(34).  These results could not be explained
by other potentially confounding factors
such as breastfeeding, watching television,
playing video games, and parental obesity.
This suggests that during the first three
months  of  pregnancy  the  fetus  is
particularly sensitive to the detrimental
effects of exposure to maternal smoke.  In
a  recent  prospective  study,  maternal
smoking  during  early  pregnancy  was
associated with overweight at three years
of age (35).  Furthermore, the effect was
observed  even  when  adjusted  for  other
factors  such  as  ethnicity,  income,
education and childhood diet.  In contrast,
an increased incidence of obesity was not
observed in children of mothers who quit
smoking prior to conception (as compared
to never smokers).  These studies suggest
that the detrimental effects of maternal
smoking on fetal development may occur
in the first trimester.  Therefore, it seems
prudent that women should be encouraged
to quit smoking before conception; as is8 Bergen H
the case with alcohol consumption.
III. Smoking and Diabetes
One of the first epidemiological studies
that identified a link between the effect of
maternal  smoking  and  the  subsequent
development of diabetes was a birth cohort
study of over 17,000 births.  In addition to
identifying  maternal  smoking  as  a  risk
factor for obesity, this study identified a
significant effect of maternal smoking on
the subsequent development of early adult
onset diabetes (20).   For example, if a
mother smoked more than 10 cigarettes a
day while pregnant, there was a four-fold
greater chance that the offspring would
develop diabetes, as compared to offspring
that  were  not  exposed  to  smoke.
Moreover in a more recent study aimed at
examining  the  effects  of  smoking  in
association with other drugs (alcohol and
illicit drugs), prenatal exposure to nicotine,
but not alcohol, had a significant effect on
subsequent  BMI  and  similar  to  other
studies, a dose response relationship was
detected  (36).   Taken  together,  these
epidemiological  studies  suggest  that
prenatal exposure to smoke has a long-
lasting  effect  on  body  weight.
Specifically, there is a greater incidence of
overweight and obesity in those exposed
to  maternal  smoke  and  that  there  is  a
significant  dose-response  relationship.
The mechanism for the effect is not known
however the authors speculated that it may
be related to either fetal malnutrition or the
toxicity of smoke on the fetus.
IV. Smoking and Hypertension
In  addition  to  nicotine’s  effect  on  the
subsequent  development  of  obesity,
maternal smoking also appears to have an
effect on the subsequent development of
cardiovascular  disease;  specifically
hypertension.   A number of studies have
provided evidence that low birth weight is
associated with hypertension later in life
(37).   Therefore,  since  smoking  during
pregnancy acts to decrease birth weight,
the  effects  of  smoking  on  subsequent
hypertension  could  occur  indirectly
through  effects  on  birth  weight.   In  a
prospective cohort study with over 1700
pregnant women, a significant effect of
maternal  smoking  during  pregnancy  on
blood pressure at six years of age was
found  and  interestingly,  this  was  not
entirely due to the effect of smoking on
birth weight (38).  In a second prospective
study of over 3,800 children, a relationship
between smoking during pregnancy and
increased blood pressure at 5 years of age
was  reported  and  the  effect  was
independent of birth weight (39).
While  the  above  studies  highlight  the
detrimental effects of maternal smoking on
the subsequent susceptibility to develop
obesity, diabetes, and hypertension, the
mechanism underlying this effect is not
well  understood  and  a  number  of
possibilities have been proposed.  Clearly,
a better understanding of how maternal
smoking, and/or nicotine, effects changes
in energy balance, metabolism, and blood
pressure,  may  lead  to  treatments  to
ameliorate  the  long-lasting  effects  of
perinatal exposure to smoke as well as
increasing the health benefits associated
with  smoking  cessation.   In  any  case,
recommendations  to  stop  smoking  are
particularly relevant in women that are
planning  or  attempting  to  become
pregnant.
V.  Smoking  and  Fetal  Origins  of
Disease: Potential Mechanisms
A.  Decreased  fetal  growth  –  As
mentioned  above,  a  number  of  studies
have found evidence of a link between low
birth weight and subsequent development
of obesity (Reviewed in (2; 7; 40; 41)).
Since maternal smoking is associated with
decreased  fetal  growth,  the  increased
incidence of obesity may be a secondary
result of being born small for gestational
age.   However  it  should  be  noted  that
while low birth weight may play a role in
subsequent  disease  processes,  there  is
evidence that the detrimental effects of
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birth weight (see above).  In any case, the
mechanism(s)  underlying  the  effect  of
nicotine on birth weight is (are) not well
understood and a number of possibilities
clearly exist.  The possibilities highlighted
below are neither exhaustive nor mutually
exclusive.
1. Low birth weight is due to smoking-
derived  nicotine  effects  on  maternal
appetite  and  energy  expenditure.
Nicotine  is  considered  to  have  an
inhibitory  effect  on  body  weight  gain.
This is supported by the association that
smokers weigh less than non-smokers and
cessation of smoking is accompanied by
significant  weight  gain  (42).   There  is
evidence to suggest that the mechanism
for nicotine’s effect on body weight may
involve  both  an  increase  in  energy
expenditure and a decrease in food intake
(43-48).  Therefore, during pregnancy the
combination  of  nicotine-induced
suppression of maternal food intake and
increased  energy  expenditure  may
collaborate  to  be  sufficient  to  produce
poor or under nutrition which then leads to
decreased  fetal  growth.   The  effect  of
smoking appears to be an effect of intra-
uterine  growth  retardation  and  not  an
effect on pre-term delivery (32).
2.  Low  birth  weight  is  due  to
detrimental  effects  of  nicotine  on
placental  structure  and  function.  A
second  possible  mechanism  responsible
for smoking’s effect on decreased fetal
growth may be at the level of the placenta;
i.e., through impaired delivery of oxygen
and/or nutrients to the fetus.  Nicotine via
activation  of  nicotinic  acetylcholine
receptors,  can  exert  a  vasoconstrictive
effect on placental arterial supply leading
to attenuation of oxygen delivery to the
fetus which in turn could lead to decreased
fetal  growth  (49-51).   Smoking  is  also
associated  with  increased  carbon
monoxide in maternal blood which in turn
reduces  oxygen  delivery  to  the  fetus
leading  to  decreased  fetal  growth.
Smoking decreases uterine blood flow to
the placenta which could play a role in
decreased fetal growth observed produced
in the smoking pregnant woman (50; 52;
53).   There are also a number of studies
that  have  reported  that  smoking  is
associated  with  marked  changes  in
placental  structure  and  function.   For
example,  smoking  is  associated  with  a
significant increase in the thickness of the
villous membrane which could predictably
lead  to  a  decrease  in  gas  and  nutrient
exchange across the placenta and impaired
fetal growth (54; 55).  Smoking also exerts
detrimental  effects  on  the  trophoblast
component  of  the  placenta  as  well  as
decreasing the area for diffusion between
the maternal blood and fetal blood   (56-
59).   For  example,  trophoblast  cell
differentiation is impaired with maternal
smoking and this effect can occur early in
the development of the placenta (58; 59).
Structural changes of the placenta may act
to  decrease  gas  exchange,  as  well  as
nutrient  exchange  (e.g.,  amino  acid
transport) across the placenta (60)  Taken
together it is clear that smoking during
pregnancy  has  significant  effects  on
placental  development  that  leads  to
significant  changes  in  structure  and
function  that  may  result  in  detrimental
effects on fetal growth and well-being
3.  Low  birth  weight  is  due  to
detrimental effects of nicotine on fetal
metabolism.   A third possibility is that
nicotine or other constituents of smoke
may have detrimental or toxic effects on
fetal metabolism that impair growth of the
fetus.   Nicotine  readily  crosses  the
placenta and therefore it could potentially
exert direct effects on fetal tissues (49).
For example, it is becoming increasingly
evident that the endocrine status of the
fetus is altered significantly in response to
maternal smoking (61; 62).  In particular,
leptin, growth hormone and insulin-like
growth  factor  (IGF)  levels  in  the  fetal
compartment are altered in response to
maternal smoke (61).   It was suggested
that decreased IGF levels detected in cord
blood associated with maternal smoking
may play a role in limiting fetal growth10 Bergen H
(62).  Of particular interest is the effect of
maternal smoke and/or nicotine on leptin
levels present in cord blood.  As discussed
below,  leptin  may  exert  profound
influences on development of the neural
systems underlying regulation of appetite
and  metabolism.   Taken  together,  it  is
clear  that  maternal  smoking  may  exert
potent  and  detrimental  effects  on  fetal
growth via a number of mechanisms.
B. Perturbations in Central Regulatory
Circuits – Most of the studies exploring
potential mechanisms underlying smoking
and disease later in life have focused on
obesity.  It is well established from animal
studies that nicotine can act within the
central nervous system to decrease food
intake and body weight (63-66).  Although
most studies examining nicotine’s effect
on  energy  balance  are  acute  studies
performed in adult animals, there is an
increasing  evidence  that  exposure  to
nicotine during development can produce
long  lasting  perturbations  in  brain
neurochemistry  including  dopamine,
serotonin, acetylcholine, and a variety of
neuropeptides, as well as leptin receptors
(67-77).  These changes could potentially
lead to long term changes in the neural
regulation of energy balance, i.e., nicotine
either  directly  or  indirectly  may  alter
appetite or self regulation of food intake in
infants exposed to maternal smoke.  It has
been proposed that smoking acts by means
of  metabolic  imprinting  on  the  system
controlling  food  intake  and  satiety.   A
number of rodent studies have provided
evidence in support of the hypothesis that
maternal nicotine has long-lasting effects
on  neurotransmitter  systems  that  are
implicated  in  the  regulation  of  energy
balance.   In  addition  there  is  recent
evidence suggesting that programming of
the  neural  circuits  that  regulate  energy
balance occurs in the perinatal period and
that metabolic or nutritional deficits result
in altered regulation of energy balance,
including appetite (78; 79).  For example,
a study in Rhesus monkeys demonstrated
that  maternal  nicotine  exposure  had  a
significant effect on gene expression of
neuropeptides  (neuropeptide  Y  and
proopiomelanocortin) in the hypothalamus
(74)..   It  is  well  established  that  these
hypothalamic  neuropeptides  can  exert
potent effects on the regulation of energy
balance and it was proposed that altered
regulation of these neuropeptides may play
a role in decreased body weight associated
with maternal smoking.   Interestingly, it
was also reported that circulating leptin
levels  were  reduced  following  nicotine
treatment,  similar  to  the  situation  that
occurs in humans (61; 74).   Decreased
leptin levels in response to nicotine is of
particular interest since a number of recent
studies  have  suggested  that  leptin  may
play a critical role in the development of
brain circuits that regulate energy balance
(80-83).   In genetically obese mice that
lack leptin (i.e., ob/ob mice), exogenous
administration of leptin had marked effects
on synaptic contacts between excitatory
and inhibitory hypothalamic neurons that
regulate  energy  balance  (82).   The
importance  of  leptin  in  development  is
further  bolstered  by  recent  studies
demonstrating that treatment with leptin
during  the  perinatal  period  can  offset
developmental programming that occurs
as a result of maternal undernourishment
(84).   Clearly,  the  role  of  leptin  as  a
hormone  that  regulates  neuronal
development  is  a  topic  of  increasing
interest and if nicotine alters circulating
leptin during development, this could have
long-term  consequences  (85).   In  this
regard it is also interesting to note that
under-nutrition  of  mouse  dams  (which
decreases  circulating  leptin)  was
associated with obesity in the pups when
they were subsequently fed a high-fat diet
(86).  This may be a mechanism by which
nutritional perturbations in the perinatal
period,  for  example  brought  on  by
maternal smoking, may have long-lasting
effects.   Taken  together  these  results
suggest  that  smoking  may  have  long
lasting  effects  on  the  neural  circuits
responsible for regulating food intake andExposure To Smoke During Development: Fetal Programming Of Adult Disease 11
metabolism.
VI. Conclusion
It is becoming increasingly clear that fetal
exposure  to  nicotine  has  numerous
consequences  to  the  detriment  of  the
health of the fetus and that these effects
may  last  well  into  adulthood.   These
effects  include  increased  incidence  of
obesity, cardiovascular disease, and non-
insulin dependent diabetes mellitus.  It is
not well understood how smoking may
produce these long-lasting effects but it is
evident that the fetal environment is of
tremendous  importance  during  the
developmental  period  in  determining
health throughout the life of the individual.
In any case, women who are planning a
pregnancy now have additional reasons to
stop  smoking  in  addition  to  the  health
benefits  that  they  will  receive  from
nicotine abstinence.   
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